Abstract
Preclinical development of human cells for potential therapeutic application in neurodegenerative diseases requires that their long-term survival, stability and functional efficacy be studied in animal models of human disease. Here we describe a strategy for long-term immune protection of human fetal and stem cell–derived neural cells transplanted into the adult rat brain, by desensitizing the host rat to similar cells in the neonatal period, without the need for additional immunosuppression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barker, R.A. et al. Cell Transplant. 9, 235–246 (2000).
Brundin, P. et al. Exp. Brain Res. 70, 192–208 (1988).
Pakzaban, P. et al. Neuroscience 62, 989–1001 (1994).
Frodl, E.M. et al. Brain Res. 647, 286–298 (1994).
Grasbon-Frodl, E.M. et al. Neuroscience 73, 171–183 (1996).
Pundt, L.L. et al. Brain Res. Bull. 39, 23–32 (1996).
Stromberg, I. et al. Brain Res. Bull. 38, 221–233 (1995).
Lund, R.D. et al. in Neural Transplantation: A Practical Approach (eds. Dunnett, S.B. & Bjorklund, A.) 161–176 (Oxford University Press, Oxford, 1992).
Pedersen, E.B. et al. Exp. Brain Res. 106, 181–186 (1995).
Stromberg, I. et al. J. Neurosci. 9, 614–624 (1989).
Armstrong, R.J. et al. Exp. Neurol. 175, 98–111 (2002).
Armstrong, R.J. et al. Exp. Brain Res. 151, 204–217 (2003).
Zietlow, R. et al. J. Anat. 207, 227–240 (2005).
Joannides, A.J. et al. Stem Cells 25, 731–737 (2007).
Brundin, P. et al. Cell Transplant. 9, 179–195 (2000).
Acknowledgements
We thank P. Morgan and A. Gallimore for advice and guidance with immunology experiments, H. Hemmings (Cornell University) for the generous gift of antibody to DARPP-32, T. Hayes for help with acquiring confocal imaging, and A. Heuer for assistance with assembling the images. These studies were supported by the UK Medical Research Council, the Lister Institute of Preventive Medicine and EU FP6 project funding.
Author information
Authors and Affiliations
Contributions
C.M.K. and S.V.P. carried out all experiments. C.S., R.P. and N.N.A. procured the human tissue. A.B. and N.D.A. prepared human embryonic stem cells. C.M.K. wrote the manuscript with S.B.D. and A.E.R., who supervised the project.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–2, Supplementary Methods (PDF 244 kb)
Rights and permissions
About this article
Cite this article
Kelly, C., Precious, S., Scherf, C. et al. Neonatal desensitization allows long-term survival of neural xenotransplants without immunosuppression. Nat Methods 6, 271–273 (2009). https://doi.org/10.1038/nmeth.1308
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nmeth.1308
This article is cited by
-
Cell-Autonomous Processes That Impair Xenograft Survival into the Cerebellum
The Cerebellum (2022)
-
Immune-tolerance to human iPS-derived neural progenitors xenografted into the immature cerebellum is overridden by species-specific differences in differentiation timing
Scientific Reports (2021)
-
Reply to "Neonatal desensitization does not universally prevent xenograft rejection"
Nature Methods (2012)
-
Neonatal desensitization does not universally prevent xenograft rejection
Nature Methods (2012)
-
Efficient derivation of NPCs, spinal motor neurons and midbrain dopaminergic neurons from hESCs at 3% oxygen
Nature Protocols (2011)
